Research Publications
Click the > symbol to read a summary of the publication.
Vipulanandan Y, Boppana S, Fowler KB, Kimberlin DW. Advancements and potential in the prevention of congenital CMV infection. Semin Fetal Neonatal Med. 2025 Sep 25:101662. doi: 10.1016/j.siny.2025.101662. Epub ahead of print. PMID: 41044015; PMCID: PMC12614814.
Congenital cytomegalovirus (CMV) is a herpes viral infection that occurs before birth. CMV is a common virus that affects people of all ages and usually does not cause symptoms in healthy children and adults. However, some babies born with CMV can have health problems at birth or that develop later, including neurodevelopmental delay and hearing loss.
Over the past 30 years, many new strategies for prevention of congenital CMV infection have emerged. These include education initiatives, behavioral modifications, and maternal antiviral prophylaxis.
In this review, authors explore different levels of congenital CMV prevention, including the potential for development of effective vaccines for CMV.
Lakshmanan K, Liu BM. Impact of Point-of-Care Testing on Diagnosis, Treatment, and Surveillance of Vaccine-Preventable Viral Infections. Diagnostics (Basel). 2025 Jan 7;15(2):123. doi: 10.3390/diagnostics15020123.
Liu BM, Yao Q, Cruz-Cosme R, Yarbrough C, Draper K, Suslovic W, Muhammad I, Contes KM, Hillyard DR, Teng S, Tang Q. Genetic Conservation and Diversity of SARS-CoV-2 Envelope Gene Across Variants of Concern. J Med Virol. 2025 Jan;97(1):e70136. doi: 10.1002/jmv.70136.
Rollman TB, Berkebile ZW, Hicks DM, Hatfield JS, Chauhan P, Pravetoni M, Schleiss MR, Milligan GN, Morgan TK, Bierle CJ. CD4+ but not CD8+ T cells are required for protection against severe guinea pig cytomegalovirus infections. PLoS Pathog. 2024 Nov 4;20(11):e1012515. doi: 10.1371/journal.ppat.1012515. eCollection 2024 Nov.
Liu BM, Hayes AW. Mechanisms and Assessment of Genotoxicity of Metallic Engineered Nanomaterials in the Human Environment. Biomedicines. 2024 Oct 20;12(10):2401. doi: 10.3390/biomedicines12102401.
Liu BM. Epidemiological and clinical overview of the 2024 Oropouche virus disease outbreaks, an emerging/re-emerging neurotropic arboviral disease and global public health threat. J Med Virol. 2024 Sep;96(9):e29897. doi: 10.1002/jmv.29897.
Liu BM, Rakhmanina NY, Yang Z, Bukrinsky MI. Mpox (Monkeypox) Virus and Its Co-Infection with HIV, Sexually Transmitted Infections, or Bacterial Superinfections: Double Whammy or a New Prime Culprit?. Viruses. 2024 May 15;16(5):784. doi: 10.3390/v16050784.
Liu BM, Li NL, Wang R, Li X, Li ZA, Marion TN, Li K. Key roles for phosphorylation and the Coiled-coil domain in TRIM56-mediated positive regulation of TLR3-TRIF-dependent innate immunity. J Biol Chem. 2024 May;300(5):107249. doi: 10.1016/j.jbc.2024.107249. Epub 2024 Mar 29.
Seasely AR, Blanchard CT, Arora N, Battarbee AN, Casey BM, Dionne-Odom J, Leal SM Jr, Moates DB, Sinkey RG, Szychowski JM, Tita AT, Subramaniam A; CWRH's COVID-19 Working Group;. Maternal and Perinatal Outcomes Associated With the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Obstet Gyneco. 2022 Aug 1;140(2):262-265. doi: 10.1097/AOG.0000000000004849. Epub 2022 May 18. PMID: 35852277.
Seasely AR, Blanchard CT, Arora N, Battarbee AN, Casey BM, Dionne-Odom J, Leal SM Jr, Moates DB, Sinkey RG, Szychowski JM, Tita AT, Subramaniam A; CWRH COVID-19 Working Group. Maternal and Perinatal Outcomes Associated With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta (B.1.617.2) Variant. Obstet Gynecol. 2021 Dec 1;138(6):842-844. doi: 10.1097/AOG.0000000000004607. PMID: 34592747.